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1. Introduction 
1.1. Metabolic diseases in cardiovascular system 
Metabolic disorders including obesity, hyperlipidemia or diabetes can 
increase the incidence of cardiovascular diseases such as myocardial 
infarction or cardiomyopathies. Therefore, it is important to study the effect 
of metabolic diseases on the cardiovascular system to identify novel targets 
for future cardioprotective therapies. 
It is known that cardioprotective effects of ischemic conditioning are 
attenuated in the presence of diabetes or hypercholesterolemia, however, it is 
still unclear which signaling pathways are responsible for the loss of 
cardioprotection in hypercholesterolemia. Furthermore, a period of 
prediabetic state (i.e., impaired glucose and insulin tolerance, insulin and 
leptin resistance, mild to moderate obesity) occurs, which may also promote 
structural and functional changes of the heart. Although cardiac 
pathophysiological alterations are relatively well characterized in fully 
developed diabetes (i.e., diabetic cardiomyopathy), consequences of 
prediabetes and their molecular mechanism is unknown in non-genetic 
prediabetic settings. 
 
1.2. Molecular pathology of metabolic diseases in the heart 
A disturbed metabolic status due to diabetes or hyperlipidemia may result 
in altered signaling pathways in cardiac cells. 
It is well-established that mechanistic target of rapamycin (mTOR) can 
be activated by various upstream regulators such as amino acids, elevated 
glucose and oxygen levels, however, the role of cardiac mTOR is still unclear 
in hypercholesterolemia and prediabetes. 
Autophagy is a ubiquitous cellular housekeeping process, which is 
involved in protein quality control and cardiac cytoprotection, however its 
role in prediabetes and hypercholesterolemia is not well studied. 
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Insufficient autophagy can promote programmed cell death, for example 
apoptosis, which results in cardiac damage. It has been shown that activated 
apoptosis has an important role in diabetes, however, the role of cardiac 
apoptosis and necroptosis in hypercholesterolemia and prediabetes is still 
unclear. 
 
1.3. Cardiac mitochondria in metabolic diseases 
Mitochondria have pivotal role in these metabolic disorders including 
obesity and type 2 diabetes, however, their status and effect is less understood 
in prediabetes. Mitochondrial function is heavily influenced by mitochondrial 
dynamics. However, it is not well-established whether altered mitochondrial 
dynamics is involved in the mechanism of deteriorated cardiac functions in 
prediabetes. 
There are three distinct fractions of cardiac and skeletal muscle 
mitochondria according to their subcellular localization: subsarcolemmal 
mitochondria (SSM), interfibrillar mitochondria (IFM), and perinuclear 
mitochondria (PNM). Moreover, the biology behind the proteomic 
differences is largely unknown, and a specific protein marker that allows the 
identification of mitochondrial subfractions has not been identified yet. 
Differentiation between IFM and SSM in biochemical assays depends on 
the use of different isolation methods. Although the use of proteases is 
necessary for the isolation of IFM by the most widely accepted method, 
enzymatic digestion with bacterial proteases might influence the 
mitochondrial protein content and/or mitochondrial function, and it is 
unknown whether the nagarse-based method for the isolation of IFM affects 
the detection of mitochondrial proteins in cardiac mitochondrial subfractions. 
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2. Aims 
 To investigate the status of autophagy and mTOR and examine apoptosis 
and necroptosis pathways in a hypercholesterolemic rat model. 
 To characterize functional, morphological and molecular features of a 
diet-induced prediabetes model in rats. 
 To investigate the effect of prediabetes on the cardiovascular system. 
 To examine whether the nagarse-based method for the isolation of IFM 
affect the detection of mitochondrial proteins in cardiac mitochondrial 
subfractions. 
 
3. Materials and methods 
These studies conform to the Guide for the Care and Use of Laboratory 
Animals published by the US National Institutes of Health (NIH publication 
No. 85–23, revised 1996) and was approved by the animal ethics committee 
of the Semmelweis University, Budapest, Hungary (registration numbers: 
XIV-I-001/450-6/2012) or animal welfare office of the Justus-Liebig 
University, Giessen, Germany. 
 
3.1. Animal models and experimental designs 
To investigate the effect of hypercholesterolemia, male Wistar rats were 
fed either normal (NORM) chow or with 2% cholesterol and 0.25% cholic 
acid-enriched diet (CHOL) for 12 weeks. Animals were anesthetized with 
diethyl ether and then they were sacrificed. Hearts were excised, briefly 
washed out, taken and snap-frozen for further experiments (Figure 1). 
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Figure 1. Experimental protocol for assessing the effect of hypercholesterolemia in 
vivo. 
Fasting blood glucose, triglyceride and cholesterol were measured at week 12. Tissue 
sampling was performed after terminal procedures. NORM, normocholesterolemic; 
CHOL, hypercholesterolemic 
 
To characterize a prediabetic animal model, male Long-Evans rats were 
fed with either control (CON) or high-fat chow (PRED) for 21 weeks and 
treated with a single low dose (20 mg/kg) streptozotocin (STZ) at week 4 
(Figure 2). Animals were allowed to food and water ad libitum. Body weights 
were measured weekly. Blood was taken and fasting blood glucose levels 
were measured from the saphenous vein every second week. To determine 
whether sensory neuropathy was developed, mechanical hind paw 
withdrawal thresholds were measured at week 15 of the diet. At the 20th week, 
oral glucose tolerance test (OGTT), insulin tolerance test (ITT) and computer 
tomography (CT) were performed. At 21th week, animals were anesthetized 
with pentobarbital. Before euthanasia, to measure cardiac function, 
echocardiography and hemodynamic measurement were performed. Then 
hearts were excised, shortly perfused with oxygenated Krebs-Henseleit 
buffer in Langendorff mode as described earlier and tissue weights were 
measured. Tissue samples were taken and snap-frozen for further 
experiments. 
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Figure 2. Experimental protocol for assessing the effect of prediabetes in vivo. 
Long-Evans rats were fed with either CON diet for 21 weeks, or with high-fat diet and 
treated with 20 mg/kg STZ at week 4 to induce prediabetes (PRED). Body weights 
were measured weekly and blood samples were taken from the saphenic vein every 
second week. Sensory neuropathy was measured at week 15. OGTT, ITT and CT were 
performed at week 20. Echocardiography, hemodynamic analysis and parameters of 
mitochondrial function were measured at week 21 of diet. Tissue sampling was 
performed after terminal procedures. CON, control; PRED, prediabetic; STZ, 
streptozotocin; OGTT, oral glucose tolerance test; ITT, insulin tolerance test; CT, 
computed tomography. 
 
To investigate the effect of nagarse on cardiac mitochondrial subfractions, 
male C57Bl6J mice and Wistar rats were used. Mice were anaesthetized with 
5% isoflurane and sacrificed by cervical dislocation. Rats were anaesthetized 
with 4% isoflurane, subsequently hearts were removed, and cardiac tissue 
was collected.  
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3.2. Biochemical measurements 
Serum cholesterol, high density lipoprotein (HDL) and triglyceride levels 
were measured in Long Evans rats and glucose, cholesterol and triglyceride 
levels were measured from plasma of NORM and CHOL Wistar rats by 
colorimetric assays. Plasma leptin was measured by enzyme-linked 
immunosorbent assay (ELISA) according to manufacturer’s instructions. To 
determine pancreatic insulin content, freeze clamped and pulverized pancreas 
samples were used according to the manufacturer’s instructions. 
 
3.3. Histology 
Heart, liver and pancreas samples were fixed in 4% neutral-buffered 
formalin and stained with hematoxylin-eosin and Masson’s trichrome 
staining. Nitrotyrosine immunostainig of left ventricular samples was also 
performed. Areas of SSM, IFM and lipid droplets were measured by 
transmission electron microscopy. 
 
3.4. Quantitative RT-PCR 
Total RNA isolation and cDNA synthesis were perfomed from left 
ventricular tissue according to the manufacturers’ instructions. Quantitative 
real-time PCR was performed with the StepOnePlus Real-Time PCR System 
(Thermo Fisher Scientific). Expression levels were calculated using the cycle 
threshold (CT) comparative method (2-ΔCT). 
 
3.5. Isolation and measurements of cardiac mitochondria 
SSM and IFM fractions from rat and mouse left ventricles were isolated 
as described by Palmer et al. in 1977 with minor modification and is referred 
to as the common protocol (Figure 3). Briefly, left ventricular tissues were 
minced with scissors in buffer A. Then, tissues were disrupted with a Polytron 
7 
 
tissue homogenizer and the homogenates were centrifuged. The supernatants 
(containing SSM) were divided into 2 groups. One portion of SSM was used 
without nagarse and protease inhibitor treatment (SSM). Another portion of 
SSM was treated with of nagarse (SSM+N; Bacterial type XXIV) for 1 min. 
Sediments of the first centrifugation (containing IFM) were resuspended in 
buffer A and were treated with nagarse for 1 min. Then, 
phenylmethylsulfonyl fluoride (PMSF) was added to one portion of IFM 
(IFM+N+I), whereas another portion was without PMSF (IFM+N). All 
mitochondrial samples were disrupted and were centrifuged. The resulting 
supernatants were centrifuged to collect the SSM and IFM. The mitochondria 
were resuspended in buffer A, and were centrifuged, and finally resuspended 
in buffer B. Then, two portions of isolated mitochondria fractions (SSM and 
IFM+N) were further used to investigate mitochondrial respiration, 
membrane potential, Ca2+ uptake and H2O2 formation from prediabetic rat 
hearts. 
For Western blot analysis, mitochondria were further purified by a 
subsequent ultracentrifugation on 30% Percoll. The lower mitochondrial 
band was collected, washed twice in buffer B by centrifugation, and the 
purified mitochondria were stored at -80°C. 
 
3.6. Western blot 
Equal amount of protein (whole left ventricle, SSM and IFM samples) 
was loaded and separated in a Tris-glycine-SDS polyacrylamide gel. Proteins 
were transferred onto a polyvinylidene difluoride membrane. Membranes 
were blocked with bovine serum albumin or non-fat dry milk. Membranes 
were probed with primary antibodies, and with corresponding horseradish 
peroxidase-conjugated secondary antibodies. Signals were detected with an 
enhanced chemiluminescence kit. 
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3.7. Statistical analysis 
Values are expressed as mean ± standard error of mean (SEM). Statistical 
analysis was performed between groups by unpaired two-tailed Student’s t-
test or by Mann-Whitney U-test. Data on mitochondrial protein levels of 
MFN1, MFN2, DJ-1, p66shc, and Cx43 in mouse and rat SSM and IFM+N 
were normalized to VDAC and compared by unpaired two-tailed Student’s t-
test or one-way ANOVA with LSD post hoc test. Mitochondrial oxygen 
consumption data was evaluated by one-way ANOVA with LSD post hoc test 
or by Kruskal-Wallis analysis with Dunn’s post hoc test in case of dataset 
with non-normal distribution. GraphPad Prism 6 software was used for 
statistical analyses. A p<0.05 value was considered significant. 
 
4. Results 
4.1. Effect of high-cholesterol diet in Wistar rats 
In this study, CHOL rats exhibited a 41% increase in plasma total 
cholesterol level over that of NORM rats (4.09 mmol/L vs. 2.89 mmol/L) at 
the end of diet period. Moreover, our Western blot results showed that hearts 
of cholesterol-fed animals exhibited a decrease in LC3-II, Beclin-1, Rubicon, 
and RAB7, consistent with downregulation of autophagy initiation and 
vesicle traffic despite upregulation of the Class-III PI3K involved in 
autophagy initiation. No difference in the expression of markers of 
autophagic clearance NBR1 and SQSTM1/p62 proteins was detected 
between groups. There was no significant difference in the expressions or 
phosphorylations of Akt and mTOR protein between groups; however, 
phosphorylation of ribosomal S6, a surrogate marker of mTOR complex 
activity, was elevated in CHOL group compared to controls. Expression of 
apoptotic marker cleaved caspase-3 was significantly increased, while Bcl-
2/Bax protein expression ratio was unchanged. Furthermore, expression of 
RIP1, RIP3 and MLKL proteins, major markers of necroptosis, were 
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unchanged. These results suggest that autophagy is attenuated, mTOR and 
apoptosis are upregulated while necroptosis is unchanged in the heart of 
hypercholesterolemic rats compared to controls. 
 
4.2. Effect of high-fat diet and streptozotocin treatment in 
Long-Evans rats 
Body weights of the prediabetic animals were moderately but statistically 
significantly elevated from week 9 as compared to the control group, and that 
this difference reached 18% at the end of the diet period. Furthermore, at 
week 20, plasma leptin level was significantly increased in prediabetes, 
plasma cholesterol, HDL cholesterol and triglyceride levels, and parameters 
of liver and kidney function were unchanged. CT scan showed that body fat 
volume of prediabetic rats was substantially increased at the end of the diet. 
Furthermore, electron microscopy showed an increased number of lipid 
droplets in the myocardium of prediabetic animals as compared to controls. 
At week 20 of the diet, fasting blood glucose levels were slightly elevated 
in prediabetes from week 10, however, remained in the normoglycemic 
range. OGTT and ITT demonstrated impaired glucose tolerance and insulin 
resistance in the prediabetic group, however, there was no difference in 
pancreatic insulin content, or in pancreatic islet morphology between groups. 
Accordingly, here we have found a decrease in the mechanical hind limb 
withdrawal threshold at week 15 of diet in the PRED, which indicates a 
moderate sensory neuropathy in this model of prediabetes. 
To determine the cardiac effect of prediabetes, we measured 
morphological and functional parameters of the hearts. Heart weights, left 
ventricular mass, left ventricular anterior wall thickness, systolic and 
diastolic left ventricular posterior wall thickness were significantly increased, 
however, heart weight/body weight ratio was decreased in prediabetes, 
plausibly due to obesity. The slope of end-diastolic pressure-volume 
relationship (EDPVR), which is a very early and sensitive marker of diastolic 
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dysfunction, was significantly elevated in prediabetes, although other 
hemodynamic parameters, including blood pressure, were unchanged. On 
hematoxylin-eosin-stained left ventricular sections increased cardiomyocyte 
diameter was detected in prediabetes. To characterize components affecting 
diastolic function, we analyzed MHC expression. Interestingly, the gene 
expression of β-MHC was decreased, and α-MHC also showed a tendency of 
decrease (p=0.17), the ratio of which resulted in a strong tendency to decrease 
in prediabetes. Mitochondrial morphology and enzyme activity were 
analyzed from left ventricles of prediabetic rats. We have not seen any major 
difference in the number of IFM between the groups, however, area, 
perimeter and sphericity of IFM are decreased in PRED group. Furthermore, 
we have not seen any major difference in mitochondrial oxygen consumption, 
enzyme activities, Ca-uptake, or membrane potential. However, we have 
found that hydrogen-peroxide production was increased in the cardiac SSM 
fraction with glutamate-malate as a substrate, although, there was no 
difference when succinate was used as substrate. Interestingly, there was no 
increase in reactive oxygen species (ROS) production of the IFM isolated 
from left ventricles supported either with glutamate-malate or with succinate. 
Nitrotyrosine immunohistology indicated that protein nitrosylation is 
increased in prediabetes. As CaMKII has been proposed to be activated in 
oxidative stress-associated conditions, we measured the levels of the active 
forms of the kinase which might affect the contractility and relaxation 
capacity of the heart. The phosphorylation of CaMKII and of its target PLB 
on Thr17 were not changed by prediabetes. Similarly, there was no change in 
the protein expression of SERCA2A in our model of prediabetes as compared 
to control animals. On the other hand, the level of p-Ser16-PLB showed a 
tendency for downregulation in prediabetes (p=0.08). Our results indicate 
that mitochondrial dynamics and autophagy/mitophagy were not modulated 
substantially by prediabetes, however, the upregulation of MFN2 (increased 
mitochondrial fusion, tethering to endoplasmic reticulum) and the 
downregulation of BNIP3 (decreased mitophagy) may implicate early 
changes in mitochondrial homeostasis, which might lead to the accumulation 
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of dysfunctional mitochondria. Our results showed no differences in the 
expression of HSP-60, HSP-70 and HSP-90 or in either phosphorylation or 
expression of HSP-27. Moreover, prediabetes did not affect the expression of 
pro-apoptotic caspase-3 and Bax in left ventricles. On the other hand, the anti-
apoptotic Bcl-2 was downregulated in prediabetic animals. However, the 
Bcl-2/Bax ratio was unchanged. 
 
4.3. Detection and quantification of proteins in cardiac 
mitochondrial subpopulations 
To examine the amounts of proteins in cardiac SSM and IFM, inner 
(Cx43) and outer mitochondrial membrane (MFN1, MFN2, VDAC) proteins 
as well as p66shc as a marker for the intermembrane space were measured. 
In Wistar rat and C57Bl6J mouse hearts, MFN2 and Cx43 protein signals 
were higher in SSM samples, while intensities of MFN1 and p66shc protein 
signals were not different between SSM and IFM+N, and DJ-1 protein signal 
was higher in IFM+N as compared to those in SSM. Nagarse treatment of 
SSM resulted in decreased signal intensities of MFN1, MFN2, and Cx43, as 
shown by Western blot analysis. In contrast, nagarse treatment had no effect 
on the amount of p66shc in SSM, whereas the level of DJ-1 slightly – but 
significantly – increased in SSM+N compared to SSM. Nagarse inhibition by 
PMSF, (IFM+N+I) had no influence on signals of Cx43, DJ-1, p66shc, and 
MFN1, whereas it significantly increased the signal intensity of MFN2 to that 
measured in SSM. Nagarse treatment had no effect on either basal or ADP-
stimulated oxygen consumption by complex I or complex II compared to 
untreated SSM. However, a tendency towards a higher complex I-mediated 
oxygen consumption was observed after nagarse treatment in SSM 
(p=0.098). Mitochondrial respiration was similar in IFM+N and IFM+N+I. 
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5. Discussion  
5.1. Hypercholesterolemia modulates cardiac mTOR and 
autophagy 
In this thesis, we show that hypercholesterolemia downregulates 
cardiac autophagy and activates mTOR pathway and apoptosis (for 
schematic representation see Figure 4).  
We assessed an increased cleaved caspase-3 activation, however, the 
balance of pro- and anti-apoptotic Bcl-2 proteins was unaffected by 
hypercholesterolemia. We show the first time the status of necroptosis in vivo 
in hypercholesterolemia. Here we demonstrate that the expression of major 
markers of necroptosis are not modulated in the heart of cholesterol-fed rats. 
Overall, our current findings demonstrate that complex metabolic 
disorders might modulate cardiac mTOR pathway and autophagy 
differentially depending on the animal model applied, and they also highlight 
that focused studies are necessary to decipher the role of specific metabolic 
pathways on autophagy. 
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Figure 4. Schematic representation of the cardiac effect of hypercholesterolemia on 
autophagy, apoptosis, necroptosis and mTOR pathways. 
PI3K CI-III, class I-III phosphoinositide 3-kinase; NBR1, neighbor of BRCA1 
gene 1; AMPKα, AMP-activated protein kinase α; GSK3β, glycogen synthase kinase-
3 beta; ULK1, unc-51-like kinase 1; LC3, microtubule-associated protein light chain 
3; RAB7, ras-related protein Rab-7a; Rubicon, run domain Beclin-1-interacting and 
cysteine-rich domain-containing protein; SQSTM1/p62, sequestosome 1; mTOR, 
mechanistic target of rapamycin; P70S6K, ribosomal protein S6 kinase beta-1; S6, 
ribosomal S6 protein; 4EBP1; eIF-4E binding protein 1; Casp3, caspase 3; Bax, Bcl-
2-associated X protein; RIP1-3, receptor-interacting serine/threonine-protein kinase 
1 and 3; MLKL, mixed lineage kinase domain-like protein. 
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5.2. Prediabetes induced diastolic dysfunction by mild 
mitochondrial oxidative stress and impaired mitophagy 
Here we demonstrate that the deterioration of diastolic function and 
sensory neuropathy occurs well before overt diabetes develops, which is 
accompanied by early signs of cardiac hypertrophy. 
Oxidative stress has a major role in the development of diabetic 
cardiomyopathy; however, it has not been well described whether it is 
responsible for the decreased cardiac function in prediabetes. Here we show 
an elevated hydrogen peroxide production in SSM, increased nitrotyrosine 
formation and an elevated cardiac expression of MFN2. However, in a 
previous study on diet-induced prediabetes, no sign of cardiac mitochondrial 
oxidative stress was evidenced in male Wistar rats after 16 weeks, which may 
implicate that mitochondrial oxidative stress might not be present in all 
models and stages of prediabetes and that it might not be the primary driving 
force of prediabetes-induced cardiac functional alterations. 
Our results evidence changes in several cellular processes, suggesting that 
hypertrophy and deteriorated diastolic function in prediabetes maybe 
consequences of numerous concurrent alterations in the cardiac homeostasis 
(see Figure 5). Characterizing active components of the contractile apparatus 
and Ca2+ homeostasis, here we observe a tendency to decrease in the Ser16 
phosphorylation of PLB in prediabetes. 
Apoptosis is considered to be one of the hallmarks of diabetic 
cardiomyopathy and it is induced by oxidative stress in diabetes. It has been 
described that experimental diabetes induces upregulation of pro-apoptotic, 
and downregulation of anti-apoptotic proteins. In this thesis, a modest 
downregulation of Bcl-2 was shown, however, no change in Bcl-2/Bax ratio, 
and in caspase-3 expression was detected in prediabetic animals. 
Here we demonstrate an early dysregulation of mitochondrial fusion and 
mitophagy first in the literature, as evidenced by an elevated MFN2 and an 
attenuated BNIP3 expression in prediabetes; however, other canonical 
markers of autophagy, mitophagy and apoptosis were unaffected. Therefore, 
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we can assume that only major disturbances in glucose and lipid homeostasis, 
such as seen in untreated patients or in genetic models of diabetes, might be 
a powerful enough signal to extensively modulate cardiac autophagy, 
mitophagy, or mitochondrial dynamics, which might result in grossly 
deteriorated cardiac function. 
 
Figure 5. Schematic representation of the cardiac effects of prediabetes.  
SSM, subsarcolemmal mitochondria; ROS, reactive oxygen species; HSP, heat shock 
protein; CAMKIIδ, Ca2+/calmodulin-dependent protein kinase II; TNFα, tumor 
necrosis factor alpha; IL-6, interleukin-6; MFN2, mitofusin 2; β-MHC, beta-alpha-
myosin heavy chain. 
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5.3. Detection of mitochondrial proteins is influenced by 
mitochondrial isolation with nagarse 
Here we evidence that nagarse, a bacterial protease commonly used for 
isolation of IFM, significantly influences the detection of MFN2 in this 
mitochondrial subfraction. Differential protease sensitivity of SSM proteins 
was also evidenced: whereas detection of MFN1, MFN2, DJ-1 and Cx43 was 
influenced by nagarse, but that of p66shc was not. Furthermore, we also 
demonstrate that mitochondrial respiration was not influenced by nagarse 
treatment. 
In this thesis, we assessed signal intensities of proteins from different 
mitochondrial compartments in control and nagarse-treated SSM. When a 
protease is added to intact mitochondria, it is reasonable to assume that first 
proteins of the outer mitochondrial membrane are digested, and indeed, the 
mitochondrial signals of MFN1 and MFN2 were reduced. However, VDAC 
signals were unaffected. The finding that the signal of p66shc – present in the 
intermembrane space - was unaffected by nagarse treatment of SSM implies 
that the extent of protein digestion by nagarse is not in the first instance 
determined by the submitochondrial localization of the protein. Furthermore, 
since the DJ-1 signal is higher in IFM+N than in both SSM and SSM+N, it is 
plausible that DJ-1 is present at higher levels in IFM, however, this finding 
needs further investigation. 
We found that Cx43 was predominantly present within cardiac SSM. 
Similarly to Cx43, MFN2 has been detected predominantly in SSM using the 
common protocol. Therefore, we recommend assessing mitochondrial 
proteins and function in IFM+N+I in studies comparing IFM and SSM and 
in case differential signal intensities of mitochondrial proteins are observed 
in SSM and IFM subfractions. 
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6. Conclusions 
In this thesis, the following original findings were demonstrated:  
 Hypercholesterolemia activates cardiac mTOR and apoptosis but 
downregulates autophagy. 
 Prediabetes induces mild diastolic dysfunction and hypertrophy by elevated 
mitochondrial oxidative stress. 
 Nagarse treatment of cardiac subsarcolemmal and interfibrillar mitochondria 
may lead to the inaccurate quantification of certain mitochondrial proteins. 
Therefore, before assessing the distribution of mitochondrial proteins, 
preliminary tests are recommended in case of proteins with unknown 
susceptibility to nagarse. 
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